SOUTH KOREA K-BPR COMPLIANCE GUIDE
Before manufacturing or importing a biocidal product for the South Korean market, check the status of each active substance for its intended use and the approval status of the finished product. The Consumer Chemical Products and Biocides Safety Control Act (K-BPR) also sets separate requirements for treated articles. For products subject to the 2026 transition, confirm whether the exact product can still be manufactured, imported or sold.
Quick Navigation
What Needs Approval Under K-BPR?
Start with the product's primary function, intended use and claims. The K-BPR Act distinguishes active substances, finished biocidal products and treated articles. A surface disinfectant and a textile treated to protect the fabric can therefore require different compliance checks.
| Regulated Item | What to Verify |
|---|---|
| Active substance | Check the substance identity, source, Korean product type and permitted use. Article 12 generally requires approval for manufacture or import of an active substance for use in a biocidal product. Verify any applicable exemption or grace period against the official designation. |
| Finished biocidal product | A product whose primary purpose is to control harmful organisms requires its own approval for manufacture or import for sale or distribution in Korea, subject to applicable statutory routes and transitions. Check the exact formulation, efficacy, approved uses and conditions under Article 20. |
| Treated article | Where the biocidal treatment serves a secondary purpose, check the treatment product and its authorized use under Article 28. Imported articles may use a product meeting Korea's statutory similarity criteria. Check the labeling duties when communicating the article's biocidal effect to buyers. |
For a product marketed mainly as a cleaner, check its classification and proposed claims before choosing the household chemical product or biocidal product route. An active substance approval is one part of the assessment. The finished formulation has a separate approval status.
Can Your Biocidal Product Still Be Sold in South Korea?
South Korea's Ministry of Climate, Energy and Environment (MCEE) explained the change for affected Group I products, including certain disinfectants and insecticides previously managed as household chemical products subject to safety verification. Their regular product approval transition ended in December 2025, followed by a stock sales period through June 30, 2026. From July 1, 2026, products in this group that lacked approval and had exhausted their applicable transition could no longer be sold or distributed. See the MCEE market circulation notice of June 24, 2026.
Products With an Additional Transition
For products that qualify for an additional transition under the Act's supplementary provisions, the notice identifies separate outer limits. Manufacture and import may continue up to the end of December 2026, while sales of eligible stock may continue up to the end of June 2027. The approval decision can change the period available to a specific product.
Verify the exact product. Search the Chorok Nuri Chemical Product Safety Portal by product name or approval number and compare the result with the approval notice or applicable transition record.
Check the activity and date. Record whether the evidence covers manufacture, import or sale on the planned date. Keep that evidence with the product's Korean label and supply records.
Track the active substance separately. The original 2019 notification window concerned existing active substances. For a current decision, verify the substance and product type against the applicable designation and grace period under Article 18.
What Should Applicants Prepare for K-BPR Approval?
Start with the proposed Korean product type, intended use and supply chain before commissioning studies. For a finished product application, Article 21 and the implementing rules provide the basis for compiling the dossier. In practice, start with the following information.
Substance and formulation. Record each active substance's identity and supplier, the full formulation and concentrations, and the Korean approval or transition evidence for the intended use.
Use and supporting data. Define target organisms, user groups, application methods and use rates. Review whether the available efficacy, hazard and exposure data cover the proposed formulation and use.
Applicant and supply route. Identify the manufacturer, Korean importer, applicant and manufacturing sites. Where applicable, assess whether an overseas manufacturer will appoint a qualified representative for the relevant duties.
How Should Product Names, Labels and Claims Be Reviewed?
Resolve the Korean product name and any additional names before filing. Check potential conflicts and keep the proposed names consistent across the application and draft artwork. For approved products, use the approval notice and the Korean regulation on biocidal product labeling to verify the label fields, including product type, approval number, approved use and precautions.
Review packaging and advertising together. Align efficacy claims, target organisms and use instructions with the approved scope. Review terms that could mislead buyers about safety, environmental impact or the product's regulatory status under Article 34 and its implementing rules.
What Changes After Biocidal Product Approval?
Screen proposed changes before implementing them. Under Article 23, changes to prescribed important matters, such as hazard or risk information or efficacy, require change approval. Other changes, such as the approval holder's name, address or contact details, follow the change notification procedure where prescribed. The K-BPR Enforcement Rules set out the respective filing procedures.
Assess changes to the formulation, active substance supplier, manufacturing site, intended use or approved name against the applicable criteria. Check which approval documents, evidence and label elements need updating before the revised product enters the supply chain.
How REACH24H Can Help
REACH24H supports K-BPR active substance and biocidal product approval projects through compliance and data gap assessments, application support and Only Representative services where applicable.
Review Your K-BPR Approval Status
Share your active substance identity, product type, intended use and any Korean approval or transition records so we can assess the next step for your project.
